Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-101296
Filing Date
2023-04-14
Accepted
2023-04-14 08:01:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d492580ddefa14a.htm DEFA14A 66990
2 GRAPHIC g492580g03w76.jpg GRAPHIC 24226
3 GRAPHIC g492580g06j74.jpg GRAPHIC 115475
  Complete submission text file 0001193125-23-101296.txt   260752
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 23819775
SIC: 2836 Biological Products, (No Diagnostic Substances)